FDA Expands Use of Antifungal Micafungin (Mycamine) to Newborns FDA Expands Use of Antifungal Micafungin (Mycamine) to Newborns

The FDA has approved the use of micafungin sodium to treat invasive candidiasis in children younger than 4 months of age.FDA Approvals

Source: Medscape Pharmacist Headlines - January 10, 2020 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news